| Vitamin K | |
|---|---|
| Vitamin name | Phylloquinone (K1), Menaquinone (K2) |
| Chemical formula | K1: C₃₁H₄₆O₂ / MK-4: C₃₁H₄₀O₂ / MK-7: C₄₆H₆₄O₂ |
| Solubility | Fat-soluble |
| Discovery year | 1930s (Nobel Prize 1943) |
| Daily requirement (RDA) | 90–120 mcg |
| Upper limit | |
| Rich food sources | K1: Well cooked leafy greens Recipe, milk, cheese, eggs K2: Hard cheeses, liver, egg yolks, dark chicken meat, grass-fed butter |
Introduction[edit]
Vitamin K is a family of fat-soluble naphthoquinones essential for blood coagulation, calcium metabolism, and cellular energy production. The name derives from the German "Koagulation." While historically viewed as a single vitamin, K1 and K2 have distinct sources, tissue distributions, and biological activities. K2 is further subdivided into menaquinones (MK-4 through MK-13), with MK-4 and MK-7 being the most studied.
Structure/Chemical Properties[edit]
All vitamin K forms share a 2-methyl-1,4-naphthoquinone (menadione) ring structure. The difference lies in their side chains:
- K1 (Phylloquinone): Phytyl side chain; found in plants
- K2 (Menaquinones): Isoprenoid side chains of varying lengths
- MK-4: 4 isoprenoid units (animal-derived or converted from K1)
- MK-7 to MK-13: Longer chains (bacterial synthesis)
- K3 (Menadione): Synthetic, no side chain; banned for human use in the US due to toxicity
The quinone structure allows vitamin K to function as an electron carrier, similar to CoQ10.
Function/Mechanism of Action[edit]
"It has many effects, some of them prevent abnormal clotting, others abnormal bleeding, others favor energy production and brain lipid synthesis, calcium regulation." - Ray Peat
Vitamin K serves as a cofactor for gamma-glutamylcarboxylase, which activates vitamin K-dependent proteins (VKDPs) via carboxylation:
| Function | Mechanism |
|---|---|
| Blood clotting | Carboxylates clotting factors (II, VII, IX, X) and anticoagulant proteins S and C in the liver |
| Bone mineralization | Activates osteocalcin, directing calcium into bone matrix |
| Soft-tissue decalcification | Activates Matrix Gla Protein (MGP), preventing arterial/kidney calcification |
| Energy production | Acts as alternative electron carrier, supporting CoQ10 function |
| Steroidogenesis | Facilitates cholesterol import into mitochondria for testosterone/progesterone synthesis |
| Insulin regulation | Activates ERGP protein in pancreatic beta-cells, regulating calcium flux and insulin secretion |
Vitamin K is activated by carbon dioxide, adequate thyroid function and carbohydrate intake support this process.
Medical Uses/Effects[edit]
| Indication | Evidence |
|---|---|
| Osteoporosis | MK-4 at 45 mg/day approved in Japan for treatment
|
| Vascular calcification | 10 mg every other day reversed arterial calcification in case studies
|
| Blood pressure | Reduces vascular stiffness, lowering BP |
| Bleeding (aspirin users) | Protective when aspirin depletes K-dependent clotting proteins |
| Testosterone support | Restores youthful testosterone in elderly animals via steroidogenesis |
| Diabetes | Protects pancreatic beta-cells; inverse correlation with diabetes risk |
| Cancer | MK-4 in clinical trials for liver cancer (HCC), leukemias, myeloproliferative disorders |
| Dental health | Noticeable effects on oral hygiene and tartar reduction |
Side/Adverse Effects[edit]
Vitamin K (natural forms) has an excellent safety profile:
- No established upper limit, insufficient evidence of toxicity even at high doses
- Japanese safety trials tested up to
135 mg/dayMK-4 for one year with no side effects except mild GI upset - Does not cause hypercoagulation in healthy individuals not on anticoagulants (K2 forms especially)
- K3 (menadione) is toxic, interferes with glutathione, causes liver damage; banned for human use
Drug interactions:
- Warfarin/anticoagulants: Vitamin K directly opposes their mechanism; requires careful management
- High-dose vitamin E: May increase bleeding risk; take vitamin K a few hours apart as protective measure
Dosing[edit]
| Goal | Form | Dose |
|---|---|---|
| Basic maintenance | K1 or K2 | 100–200 mcg/day
|
| Aspirin protection | K2 | 500 mcg–1 mg/day
|
| Osteocalcin carboxylation (minimum) | MK-4 | 1 mg/day
|
| Bone/muscle/brain benefits | MK-4 | 1–5 mg/day
|
| Therapeutic (osteoporosis, calcification) | MK-4 | 10–45 mg/day
|
| Weekly high-dose approach | MK-4 | 45 mg once weekly
|
Notes:
- Take with fat for absorption
- Olive oil is a preferred vehicle; avoid MCT oil orally (topical use acceptable)
- MK-7 has longer half-life (~72 hours) vs MK-4 (shorter), affecting dosing frequency
Positive interactions:[edit]
Vitamin K2 guides calcium to the bone and teeth while also removing it from arterial plaque.[1]
Brands and sources[edit]
| Brand/Product | Form | Notes |
|---|---|---|
| Thorne Research K2 Drops | Liquid MK-4 | Ray Peat directly recommended; 1 mg per drop; mentioned in multiple interviews as the go-to
|
| IdeaLabs Kuinone | Liquid MK-4 (2 mg/drop)
|
Dissolved in SFA esters + ethanol or olive oil (EVOO option available); created as cheaper alternative to Thorne |
| IdeaLabs EstroBan | Combo (K2 + A + D + E) | MK-4 with other fat-solubles for synergy |
| Life Extension MK-4 | 45 mg capsules
|
Mentioned in forum discussions for high-dose protocols |
Ray Peat's leafy greens recipe
References[edit]
- ↑ Rheaume-Bleue, K. (2011). Vitamin K2 and the calcium paradox: How a Little-Known Vitamin Could Save Your Life. John Wiley & Sons.